{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T06:03:54Z","timestamp":1791353034438,"version":"4.3.1"},"reference-count":10,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2015,3,1]],"date-time":"2015-03-01T00:00:00Z","timestamp":1425168000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["cell.com","bmn.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Molecular Medicine"],"published-print":{"date-parts":[[2015,3]]},"DOI":"10.1016\/j.molmed.2015.01.005","type":"journal-article","created":{"date-parts":[[2015,2,10]],"date-time":"2015-02-10T13:31:59Z","timestamp":1423575119000},"page":"145-147","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":36,"title":["Molecular and immunological biomarkers to predict IVIg response"],"prefix":"10.1016","volume":"21","author":[{"given":"Caroline","family":"Galeotti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Srini V","family":"Kaveri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jagadeesh","family":"Bayry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.molmed.2015.01.005_bib0055","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/j.jpeds.2010.10.031","article-title":"Evaluation of Kawasaki disease risk-scoring systems for intravenous immunoglobulin resistance","volume":"158","author":"Sleeper","year":"2011","journal-title":"J. Pediatr."},{"key":"10.1016\/j.molmed.2015.01.005_bib0060","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1016\/j.jaci.2008.09.011","article-title":"Elevated granulocyte colony-stimulating factor levels predict treatment failure in patients with Kawasaki disease","volume":"122","author":"Abe","year":"2008","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.molmed.2015.01.005_bib0065","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/j.humimm.2010.06.008","article-title":"Transcript abundance patterns in Kawasaki disease patients with intravenous immunoglobulin resistance","volume":"71","author":"Fury","year":"2010","journal-title":"Hum. Immunol."},{"key":"10.1016\/j.molmed.2015.01.005_bib0070","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1002\/art.37815","article-title":"Evaluation of intravenous immunoglobulin resistance and coronary artery lesions in relation to Th1\/Th2 cytokine profiles in patients with Kawasaki disease","volume":"65","author":"Wang","year":"2013","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.molmed.2015.01.005_bib0075","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1038\/ng.981","article-title":"Genome-wide association study identifies FCGR2A as a susceptibility locus for Kawasaki disease","volume":"43","author":"Khor","year":"2011","journal-title":"Nat. Genet."},{"key":"10.1016\/j.molmed.2015.01.005_bib0080","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1161\/CIRCGENETICS.111.962464","article-title":"Role of activating FcgammaR gene polymorphisms in Kawasaki disease susceptibility and intravenous immunoglobulin response","volume":"5","author":"Shrestha","year":"2012","journal-title":"Circ. Cardiovasc. Genet."},{"key":"10.1016\/j.molmed.2015.01.005_bib0085","article-title":"DNA methylation array identifies genomic hypomethylation of FCGR2A in the susceptibility of Kawasaki disease and intravenous immunoglobulin resistance","author":"Kuo","year":"2014","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.molmed.2015.01.005_bib0090","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.jaci.2011.04.027","article-title":"Functional FCGR2B gene variants influence intravenous immunoglobulin response in patients with Kawasaki disease","volume":"128","author":"Shrestha","year":"2011","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.molmed.2015.01.005_bib0095","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1182\/blood.V100.5.1774.h81702001774_1774_1779","article-title":"Expression patterns of Th1 and Th2 cytokine genes in childhood idiopathic thrombocytopenic purpura (ITP) at presentation and their modulation by intravenous immunoglobulin G (IVIg) treatment: their role in prognosis","volume":"100","author":"Mouzaki","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.molmed.2015.01.005_bib0100","doi-asserted-by":"crossref","first-page":"e2109","DOI":"10.1371\/journal.pone.0002109","article-title":"Prominent plasmacytosis following intravenous immunoglobulin correlates with clinical improvement in Guillain-Barre syndrome","volume":"3","author":"Mori","year":"2008","journal-title":"PLoS ONE"}],"container-title":["Trends in Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471491415000192?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471491415000192?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,8,29]],"date-time":"2020-08-29T21:50:26Z","timestamp":1598737826000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1471491415000192"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3]]},"references-count":10,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,3]]}},"alternative-id":["S1471491415000192"],"URL":"https:\/\/doi.org\/10.1016\/j.molmed.2015.01.005","relation":{},"ISSN":["1471-4914"],"issn-type":[{"value":"1471-4914","type":"print"}],"subject":[],"published":{"date-parts":[[2015,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Molecular and immunological biomarkers to predict IVIg response","name":"articletitle","label":"Article Title"},{"value":"Trends in Molecular Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.molmed.2015.01.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}